 increase brain 17-hydroxy-DHA formation, a precursor of antiinflammatory resolvins, indicating a new antiinflammatory therapeutic action of lithium (Basselin et al., 2010). PARKINSON DISEASE MODEL UPREGULATED BRAIN ARACHIDONIC ACID ENZYMES
increase brain 17 - hydroxy - DHA formation, a precursor of antiinflammatory resolvins, indicating a newfangled antiinflammatory curative action of lithium (Basselin et al. , 2010). PARKINSON DISEASE MODEL UPREGULATED BRAIN ARACHIDONIC ACID ENZYMES
 infrease brain 17-hydroxy-DHA normation, a precorwor of antiihflammatury resolvins, indicating a nxw abtiindlammatory therapeutic action ov lithiun (Bawwelin et al., 2010). PARKIKFON SLSEASZ NODEL UPREGULAJED BRAIN ARDCHIDONIC ACID EVZVMES
increase brain 17-hydroxy-DHA formation, a precursor of indicating new antiinflammatory action of lithium DISEASE UPREGULATED BRAIN ARACHIDONIC ENZYMES
 increase brain 17-hydroxy-DHA foRmation, a prEcursOr oF anTiInflAmmaTory resolvins, iNDicaTing a new antiinflammatoRy theRaPEutiC AcTion oF lithiuM (baSSEliN eT aL., 2010). PArKinSoN DISeASe MODEL UpREGULATED bRAiN aRACHIDONIC AciD eNZYMES
 increase brain 17-hydroxy -DHA forma tion,  apre cu rsor  ofantiinflammato r y re solvins, indicating anew a nt i infl a mm atory  therap e ut i c  ac ti on  of  l i th ium ( Bas selin e t al., 201 0).  P ARKINSON DIS E AS E MODEL UP REG ULATED BRAIN  AR ACHIDO NI C A C ID EN ZYM ES
 increase_brain 17-hydroxy-DHA_formation, a precursor of_antiinflammatory resolvins,_indicating_a new_antiinflammatory_therapeutic action of_lithium (Basselin et_al., 2010). PARKINSON DISEASE_MODEL UPREGULATED BRAIN_ARACHIDONIC_ACID ENZYMES